Our study also demonstrated that GO-Y030 is a potent inhibiting STAT3 for cancer stem cells and is a good drug candidate to target constitutive STAT3 signalling in colorectal cancer stem cells or cancer-initiating cells. Here, STAT3 is linked to cancer.